Acorda Theraputics
CV 6.0% · CUSIP 00484MAB2
1
institutional holders
+0 vs Q1 2021
$4.0mprincipal reported held*
$3.0mreported value*
0 new
1 added
0 reduced
0 sold out
net bought ≈ $1.1m
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 1 |
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 1 | 0 |
Biggest buyers
| Bruce & Co., Inc. | Added | +1.5m |
Biggest sellers
| None |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| Bruce & Co., Inc. 0.57% of their portfolio | 4.0m $3.0m | Added +1.5m |